MiniMed Group, Inc. (MMED) has no trailing P/E shown and a forward P/E of 33.75x. This places MMED in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.
MMED Stock — Price, Charts & Analysis
Stock research report
MMED Stock Fundamentals & Technical Report
MMED is reviewed here as a complete stock research report for the NasdaqGS market, bringing the core signals into one place: today's price action, valuation, earnings power, balance-sheet quality, cash flow, dividends, ownership, analyst expectations, RSI, support, resistance, moving averages, and technical momentum. The report is built from the data available on Worldtickers and keeps the company name front and center while preserving the ticker for quick market lookup.
Fundamental Research
MMED Fundamental Analysis
MMED Valuation Snapshot
MMED trades with 33.75x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MMED looks overvalued or undervalued.
MMED's P/E of 33.75x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.
MMED's trailing EPS is -$1.30 and forward EPS is $0.66.
EPS, or earnings per share, shows how much profit MiniMed Group, Inc. generated for each share. MMED's trailing EPS is -$1.30, and investors usually prefer EPS that is positive and growing over time.
MiniMed Group, Inc. has a market cap of $6.22B, making MMED a mid-cap stock based on the current market value shown on Worldtickers.
MMED's latest stock price on Worldtickers is $22.11. The latest move is $1.85 or 9.13%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.
MMED's quote includes a latest price of $22.11. The market open is $20.40. Previous close is $20.26. The intraday range is $19.71 to $22.63.
MMED is up in the latest quote, with a move of $1.85 or 9.13%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.
MMED Business Fundamentals
MMED generated $3.10B in trailing revenue. Revenue growth is 15.60%, which helps show whether demand is expanding or slowing.
MMED's revenue growth is 15.60%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.
No, MMED does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$333.00M.
Gross margin is 57.06%. Margins show how efficiently MiniMed Group, Inc. turns revenue into profit.
MiniMed Group, Inc. carries $53.00M and holds $298.00M in cash.
MMED holds $298.00M on its balance sheet.
MMED's book value per share is $12.86.
MMED Ownership Signals
Institutions hold 13.35% of MMED shares. Insiders hold 89.92% of shares. Ownership mix helps investors understand how much of MiniMed Group, Inc. is held by professional investors and company insiders.
Insider activity can be useful context for MMED, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.
MMED Earnings Outlook
Forward EPS for MMED is $0.66. Revenue growth is 15.60%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.
MMED's trailing EPS is -$1.30. Forward EPS is $0.66. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.
MMED Investment View
MMED is in the Healthcare sector. Its earnings multiple is 33.75x. Its latest displayed growth metric is 15.60%. Compare these figures with sector peers before deciding whether MiniMed Group, Inc. is stronger or weaker than average.
MMED trades at $22.11. The stock trades at 33.75x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of MiniMed Group, Inc.'s fundamentals.
MMED risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. No single stock should be evaluated without portfolio context.
MMED should be compared with companies in Medical Instruments & Supplies. Its earnings multiple is 33.75x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.
MMED Company Profile
MiniMed Group, Inc. (MMED) operates in Healthcare, specifically Medical Instruments & Supplies. MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insu
MMED trades on NasdaqGS. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.
MMED stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.
MiniMed Group, Inc.'s official website listed on Worldtickers is www.minimed.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.
MiniMed Group, Inc. employs about 8K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.
MiniMed Group, Inc. is headquartered in Northridge, CA, United States. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.
MMED is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.
Technical Research
MMED Technical Analysis
MMED has traded between $10.65 and $22.63 over the past 52 weeks. At $22.11, it is 2.30% below the high and 107.61% above the low. The 52-week range helps gauge long-term price momentum.
MMED is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $17.60 and its 200-day moving average is $15.33.
MMED's RSI is 70.65. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a overbought momentum setup.
MMED's latest RSI reading is 70.65, which points to overbought momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.
Key support for MMED is near $18.19. Key resistance is near $20.88. Breaks above resistance or below support can change the short-term technical setup.
MMED's nearest reported support level is $18.19. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.
MMED's nearest reported resistance level is $20.88. A breakout above resistance can improve momentum, especially when volume confirms the move.
MMED trades about 1.22M shares daily on average. The latest displayed volume is 3.21M shares. Volume helps show liquidity and whether trading interest is unusually high or low.
MMED's MACD is -0.00, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.
MMED is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 70.65 (overbought). MACD is bearish. Nearest support is around $18.19. Resistance is around $20.88. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.
MA20 is $19.84 (11.44% from price). MA50 is $17.60 (25.59% from price). MA200 is $15.33. The moving-average stack helps separate short-term momentum from long-term trend risk.
The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MMED's MA20 is $19.84. MA50 is $17.60. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.
MMED's pivot is near $20.12. Support is near $18.19. Resistance is near $20.88. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.
The next lower support zone for MMED is near $19.00. These levels help define risk and possible follow-through zones after a breakout or breakdown.
MMED's Bollinger range is roughly $18.28 to $21.40. Band width is near 15.71%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.
MMED's ATR-based typical daily range is about 4.62%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.
Latest volume is 3.21M shares. Average volume is about 1.22M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.
MMED's all-time high shown on Worldtickers is $20.88. Its all-time low is $10.65. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.
AI Market Desk
Free plan
3/3Login